28751768 |
Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia
Jawhar, M,
Tapper, W,
Metzgeroth, G,
Chacko, J,
Score, J,
Chase, A,
Kreuzer, KA,
Knut, M,
Naumann, N,
Cross, NCP,
Schneider, B,
Hofmann, WK,
Fabarius, A,
Hallek, M,
Drexler, HG,
Ghazzawi, M,
Wallis, L,
Reiter, A
|
|
2017 |
31066629 |
FMS-like Tyrosine Kinase 3/FLT3: From Basic Science to Clinical Implications
Kazi, JU,
Rönnstrand, L
|
Physiol. Rev. |
2019 |
19345670 |
The juxtamembrane domain in ETV6/FLT3 is critical for PIM-1 up-regulation and cell proliferation
Xinh, PT,
Vu, HA,
Kano, Y,
Tokunaga, K,
Sato, Y
|
|
2009 |
21705501 |
Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3
Score, J,
Erben, P,
Haferlach, C,
Gesk, S,
Ritter, M,
Telford, N,
Haferlach, T,
Reiter, A,
Cross, NC,
Metzgeroth, G,
Hofmann, WK,
Walz, C,
Bloor, A,
Hochhaus, A
|
|
2011 |
30559310 |
Two myeloid leukemia cases with rare FLT3 fusions
Olson, S,
Zhang, H,
Moore, S,
Long, N,
Paliga, A,
Hobbs, E,
Tyner, JW,
Dao, KT
|
|
2018 |
23168613 |
Direct binding of Grb2 has an important role in the development of myeloproliferative disease induced by ETV6/FLT3
Ishikawa, T,
Kawamata, S,
Ohno, T,
Chonabayashi, K,
Hishizawa, M,
Uchiyama, T,
Nagai, Y,
Takaori-Kondo, A
|
Leukemia |
2013 |
28028030 |
Myeloid neoplasms with eosinophilia
Gotlib, J,
Reiter, A
|
|
2017 |
16761019 |
FLT3 is fused to ETV6 in a myeloproliferative disorder with hypereosinophilia and a t(12;13)(p13;q12) translocation
Sato, Y,
Vu, HA,
Motoji, T,
Sakaki, Y,
Xinh, PT,
Tokunaga, K,
Toyoda, A,
Masuda, M
|
|
2006 |
29025582 |
A novel TRIP11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophilia
Fisk, DG,
Fire, AZ,
Gojenola, L,
Li, X,
Arber, DA,
Gotlib, J,
Roskin, KM,
Von Gehr, A,
Hou, Y,
Zehnder, JL,
Bangs, CD,
Cherry, AM,
Ohgami, RS,
Merker, JD,
Chung, A
|
|
2017 |
27795560 |
A novel t(3;13)(q13;q12) translocation fusing FLT3 with GOLGB1: toward myeloid/lymphoid neoplasms with eosinophilia and rearrangement of FLT3?
Petit, B,
Dobbelstein, S,
Chauzeix, J,
Touati, M,
Gachard, N,
Faumont, N,
Bertrand, P,
Troadec, E,
Trimoreau, F,
Bordessoule, D,
Bastard, C,
Feuillard, J
|
|
2017 |
17268528 |
Transgenic mice expressing Tel-FLT3, a constitutively activated form of FLT3, develop myeloproliferative disease
Collector, M,
Racke, F,
Small, S,
Sharkis, SJ,
Whartenby, KA,
Li, L,
Baldwin, BR,
Tse, KF,
Huso, D,
Small, D
|
|
2007 |
17764812 |
A constitutively active SPTBN1-FLT3 fusion in atypical chronic myeloid leukemia is sensitive to tyrosine kinase inhibitors and immunotherapy
Grand, FH,
Zhang, L,
Russell, NH,
Cross, NC,
Chase, A,
Iqbal, S
|
|
2007 |
24854988 |
ETV6-FLT3 fusion gene-positive, eosinophilia-associated myeloproliferative neoplasm successfully treated with sorafenib and allogeneic stem cell transplant
Popat, U,
Falchi, L,
Patel, KP,
Lyle, LM,
Luthra, R,
Mehrotra, M,
Newberry, KJ,
Verstovsek, S,
Lu, G
|
|
2014 |